aripiprazole

Known as: Aripiprazol, 7-(4-(4-(2,3-dichlorophenyl)-1-piperazinyl)butyloxy)-3,4-dihydro-2(1H)-quinolinone, Aripiprazole [Chemical/Ingredient] 
A quinoline derivate and atypical anti-psychotic agent. Aripiprazole has partial agonistic activity at dopamine D2 receptors and serotonin 5-HT1A… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
OBJECTIVE The objective of this study was to evaluate short-term efficacy and safety of aripiprazole in the treatment of… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2009
Highly Cited
2009
BACKGROUND Because of the debate about whether second-generation antipsychotic drugs are better than first-generation… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
OBJECTIVE To assess the efficacy and safety of aripiprazole versus placebo as adjunctive treatment to standard antidepressant… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Aripiprazole is a unique atypical antipsychotic drug with an excellent side-effect profile presumed, in part, to be due to lack… (More)
  • table 1
  • figure 1
  • figure 3
  • figure 2
  • figure 4
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Atypical antipsychotic drugs have revolutionized the treatment of schizophrenia and related disorders. The current clinically… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2003
Highly Cited
2003
BACKGROUND Aripiprazole is a dopamine D2 receptor partial agonist with partial agonist activity at serotonin 5HT1A receptors and… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2003
Highly Cited
2003
OBJECTIVE The authors compared the efficacy and safety of aripiprazole, a novel antipsychotic, to placebo for treatment of… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Aripiprazole is a novel atypical antipsychotic for the treatment of schizophrenia. It is a D2 receptor partial agonist with… (More)
  • table 1
  • table 2
  • figure 2
  • figure 1
  • table 3
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Aripiprazole is the first next-generation atypical antipsychotic with a mechanism of action that differs from currently marketed… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2002
Highly Cited
2002
BACKGROUND Aripiprazole is an investigational agent for treating schizophrenia that has a novel pharmacologic profile. The… (More)
Is this relevant?